Required for next week
- Choice(s) of essay topics due next week.
-
No new reading for next week. Please have another look at the
second hand smoke papers, and the cheating papers.
Some notes on the smoking video
(Program Tape 11 from Against All Odds)
Prospective and retrospective studies
A distinction is made in the video between prospective and retrospective
studies. A retrospective study identifies a group of people with a disease
(or other outcome), and tries to ascertain potential risk factors in
retrospect. This is usually done by identifying another group of people
who do not have the disease in question, and comparing these two groups
on their exposure to a possible risk factor. In medical applications,
this type of study is often called a case-control study: the cases are the
people with the disease, and the controls are the disease-free comparison
group. For example, one study of the effect of second-hand smoke on spouses
([ JAMA]), identified 653 non-smoking women with lung cancer, and
collected data on how many of these were married to smokers. They identified
a further group of 1,253 non-smoking women without lung cancer, and also
collected data on how many of these were married to smokers.
A prospective study identifies a group of healthy people and follows them
over time, to ascertain who gets the disease and who doesn't, and then compares
these two groups on their potential risk factors. In medical applications
a prospective study is often called a cohort study. The smoking video
referred to early evidence from retrospective studies being confirmed in
a large prospective study.
(An opinion poll or other type of survey is more like a prospective
study, although the data from particular individuals is usually only collected
at one time point.)
A major disadvantage of a case-control study is that the controls are usually
chosen by convenience. Very often the controls are patients in the same
hospital, who have been hospitalized for a condition unrelated to the disease
under study. Thus there is no guarantee that the controls are really
comparable to the cases. In a prospective study, effort is usually made to
measure many variables potentially related to the disease, so that the
comparison can be fine-tuned at the end of the study. Another disadvantage
of a case-control study is that people are asked about their exposure to
a risk factor in retrospect, and this can provide quite unreliable data.
Both these criticisms were made of the initial studies suggesting a link
between smoking and lung cancer, and both these criticisms are made by
Gross in his article about second-hand smoke (last week's reading).
A major disadvantage of prospective studies is that it is necessary to follow
a very large group of people over a long period of time, especially when
investigating rare diseases or diseases that take a long time to appear.
This is not only expensive, it is also very difficult to get complete data,
and biases can result if loss to followup is related to the outcome of interest.
Both prospective and retrospective
studies are observational studies, as opposed to experiments.
Experiments require active intervention on the part of the researchers,
something often not possible in medical research or other research involving
human subjects.
Confounding variables
All observational studies can potentially be skewed by confounding variables.
These are variables that are not of primary interest, and may not even
be measured, but are correlated with the response of interest. For
example, in the smoking video, the possibility was mentioned that alcohol
consumption and lung cancer incidence were associated. Since we might also
expect that smoking and alcohol consumption are related, the observed
increase in lung cancer among smokers might only reflect the association
of lung cancer and alcohol consumption.
In the polling for the Quebec referendum, potential confounding variables
that were mentioned (and adjusted for when allocating the undecideds)
included gender, age, and first language.
In observational studies effort is usually made to identify all possible
confounding variables, and adjust for them in the analysis of the data.
But it is impossible to adjust for confounding variables that no one has
thought of yet.
Criteria for causality
It can be argued that observational studies can never establish a causal
relationship between two variables, such as smoking and lung cancer: that
causality can only be established by experimentation involving direct
intervention. However, the science of epidemiology, which
studies various aspects of public health, deals almost exclusively with
observational studies, and as a result have identified a series of
criteria for deciding that a causal relationship is very likely. In fact,
these criteria were originally developed by Sir Richard Doll
in connection with studies on lung cancer and smoking in Britain
in the fifties. The five criteria mentioned on the video are:
- consistency of the association
- strength of the association
- specificity of the association
- temporal relationship between potential cause and effect
- coherence of the association
Simpson's paradox
A particularly intriguing type of confounding occurs when a confounding
variable, once exposed, completely turns around the observed association.
Here is an example, from [ Rad], on the relationship between race and the
imposition of the death penalty for convicted first-degree murderers.
race of death penalty death penalty
defendant imposed not imposed percentage
----------------------------------------------------------
white 19 141 11.88%
black 17 149 10.24%
The imposition of the death penalty is about the same rate for white and black
defendants, in fact, slightly higher for white defendants.
However, when the race of the victim
is taken into account, a quite different picture emerges:
white victim
race of death penalty death penalty
defendant imposed not imposed percentage
----------------------------------------------------------
white 19 132 12.58%
black 11 52 17.46%
black victim
race of death penalty death penalty
defendant imposed not imposed percentage
----------------------------------------------------------
white 0 9 0%
black 6 97 5.83%
References
- JAMA
- Reported in
Chance News 3.08
,
J. American
Medical Association, June 8, 1994.
- Rad
- Radelet, M. (1981) Racial characteristics and imposition
of the death penalty. American Sociological Review 46, 918--927.
There is a related article in
Chance News 4.04
from the New York Times, February 24, 1995.
- []
- The book Statistics: concepts and controversies by Moore
has a nice section on causality, smoking and cancer: Chapter 6, Section 3.
In the Globe and Mail this week
- ``Procedure helps disease sufferers", Nov. 24 (A10).
A surgical procedure called palliodotomy may help sufferers of Parkinson's
disease. It has been performed on 80 patients in the past 3 1/2 years:
results of a study on the first 14 patients was published in the November
25 issue of Lancet.
- ``Discovery may slow heart failure", Nov. 23 (A9).
A new drug for treating high blood pressure has been
undergoing tests in several Canadian hospitals. An unexpected finding
is that the drug appears to be effective for congestive heart disease:
the death rate in patients with congestive heart failure was reduced
by 45 \%. Although the result has yet to be reported in a medical
journal, doctors have immediately moved into a
second test using the drug specifically on patients with CHD.
- ``When the big shift in spending took place", Nov. 20 (A8).
A rather confusing article with a really confusing graphic, arguing
(I think) that Ottawa's share of spending has been around its current
level of 40\% fairly consistently over the past 30 years.
- ``Canadians clamour for illegal 'cure-all'", Nov. 18, (A1) and (A13).
Melatonin is being advertised as a sleep aid and a potential cure
for a range of problems. It is available as a dietary supplement in the U.S.,
and although it is illegal to sell it in Canada, it is available by
mail order and through some health food stores. A book is mentioned,
rather disparagingly: The Melatonin Miracle, by W. Regelson.
- ``Canadian imbibing habits change", Nov. 18.
"A Health Canada survey ... found that the number of Canadians describing
themselves as 'current drinkers' fell to 72.3 \% in 1994 from 77.7 \% in 1989...
Few drinkers feel that their alcohol consumption has ever caused them harm;
almost 80 \% said it had not. However 73.4\% of those surveyed said they
had been harmed in some way at some time by another's drinking."
- A full page ad on page A7, Saturday, November 18 by Bristol-Myers Squibb,
announcing that ``this week the results of a long awaited landmark study
which measure the effect of cholesterol-lowering medication on 6,595
patients, were released. The outcome of this study conducted by the
University of Glasgow, in the West of Scotland, showed that a specific drug
was associated with an early and lasting reduction in the risk of a first
heart attack and death. Initial effects were seen within six months of
treatment with few side effects.'' An article about the study appeared
in the New York Times on Nov.~16, 1995, and is available in
Chance News 4.15
The study results were reported in that
week's New England Journal of Medicine. From Chance News:``the
study was supported by a grant from the Bristol--Myers Squibb Company, which
makes pravastatin [the drug that was tested in the study]
and sells in under the name Pravachol... an accompanying editorial
[in the NEJM] comments that these drugs are expensive,
costing about \$800 a year per person. The editorial suggested pursuing
less expensive solutions such as using certain kinds of margarine that
have been shown to have an ability to lower cholesterol"
Technical note: relative risk
The relative risk for an event or outcome, such as lung cancer,
due to a risk factor, such as smoking,
is the ratio of the probability of the event, given exposure to the
risk factor to the probability of the event, given non-exposure to the
risk factor. If you like formulas:
Prob(event|exposure)
relative risk = ----------------------------
Prob(event|non-exposure)
If the relative risk is equal to 1, then there is no (apparent) increase
in the probability of disease, due to the risk factor. If the relative risk is
greater than 1, then exposure to the risk factor does increase the probability
of disease, and if the relative risk is less than 1, exposure decreases
the probability of disease. Of course in studies, the relative risk
can only be estimated, and there is always an associated margin of error.
In the smoking and lung cancer studies, the relative risk for lung
cancer identified with smoking was 9, for one-pack-a-day smokers, and
30 for two pack-a-day-smokers. In the ETS studies, the relative risk
for lung cancer identified with exposure to second-hand smoke was between 1 and
2 in most studies, and overall was about 1.13. This means an increase of
13\% in the probability of lung cancer due to exposure to ETS. Since the
lung cancer incidence is already very small, about 1/10,000 (?), this doesn't
translate into very many additional expected cases of lung cancer. (The
EPA study identified a relative risk of 2, which translated into
an estimated 3000 additional cases of lung cancer in the U.S.; a guesstimate
for Canada would be 300, since the population is about 1/10 the size.)
Even more technical
In case-control studies, which all the ETS studies are, the relative risk
must be estimated indirectly, by the so-called
odds ratio, which is the ratio of the odds of the event,
given exposure, to the odds of the event given non-exposure:
odds of event|exposure
odds ratio = -----------------------------------
odds of event|non-exposure
Prob(event|exposure)/Prob(non-event|exposure)
= -----------------------------------------------
Prob(event|non-exposure)/Prob(non-event|non-exposure)
One further technical point is that the margin of error for the estimate of
relative risk is computed as a 'plus-or-minus' on the log-scale, which
is why Gross exhibits his summary of the studies this way.